Active specific immunotherapy; BCG: Bacille Calmette–Guérin; KLH: Keyhole limpet hemocyanin; MPL: Monophosphoryl lipid A; NSCLC: Non-small-cell lung cancer. Various adjuvant products are ...

and lung. The term can apply to multiple types of specific therapies, including chemotherapy, radiation, hormone therapy, and ...

This may be the case with whole tumor vaccine strategies with detrimental outcome, such as GVAX immunotherapy ... larger multicenter adjuvant vaccine clinical trials in cancer patients are ...

Roche's drug is the first cancer immunotherapy to be approved by the FDA for adjuvant treatment of NSCLC ... and patients a new way to treat early lung cancer that has the potential to ...

Experts from various tumor fields, including lung cancer, hepatobiliary ... effectiveness and high safety of the 'neo-adjuvant bladder preservation immunotherapy model' with Chinese characteristics.

Durvalumab is recommended, within its marketing authorisation, as neoadjuvant treatment with platinum-based chemotherapy, then continued alone as adjuvant treatment, for treating non-small-cell lung ...

Cancer is now the second leading cause of death worldwide, and rates are climbing-especially in younger adults. Breast, ...

The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which ...